Cysticercosis clinical trials
The registry lists 10 studies for Cysticercosis across 8 countries. 2 are recruiting or about to start. 5 of them are mainly about Cysticercosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its narrower condition Neurocysticercosis too: 28 studies, 5 open.
Get an email when these change. Save the Cysticercosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (3) · University of Oklahoma (1) · University of Zambia (1) · University of Oslo (1) · Universidad Peruana Cayetano Heredia (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Johns Hopkins University (1) · Oregon Health and Science University (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 1 Cysticercosis studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (100%) | 1 (100%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 10 studies, recruiting or not: 50% stop at 75 or younger and 20% at 65; 60% take children; 0% are for women only and 0% for men only; 40% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. search them.
- Natural History of Treated Neurocysticercosis and Long-Term OutcomesRecruitingNCT000012051 country
- Oxfendazole in Mild Parenchymal Brain CysticercosisNot yet recruitingNCT06565507Phase 2/3
- Two Cases of Pulmonary Cysticercosis Manifesting as Pleural Effusion: Case Report and Literature ReviewCompletedNCT05010811
- Digital Health Promotion in Iringa, TanzaniaCompletedNCT03808597Not applicable1 country
- RCT ALB for SA CysticercosisWithdrawnNCT00133458Phase 34 countries
- EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina FasoCompletedNCT03095339Not applicable1 country
- Brain Tissue Swelling and Seizure Activity in Inactive CysticercosisCompletedNCT000019122 countries
- Randomized Study of Albendazole in Patients With Epilepsy Due to NeurocysticercosisCompletedNCT00004403Not applicable
- Taenia Solium Control Case Study in ZambiaCompletedNCT01368354Not applicable1 country
- Targeted Screening for Taenia Solium TapewormsCompletedNCT01296958Not applicable1 country